Coronary revascularization in diabetic patients: A systematic review and bayesian network meta-analysis

Annals of Internal Medicine

Volumn 161, Issue 10, 2014, Pages 724-732

  Tu, Benny ^a   Rich, Ben ^b   Labos, Christopher ^b   Brophy, James M ^b  

^a GREENSLOPES PRIVATE HOSPITAL   (Australia)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BARE METAL STENT; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; FOLLOW UP; HEALTH CARE COST; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; LEFT CORONARY ARTERY; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PUBLICATION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STUDY DESIGN; SYSTEMATIC REVIEW; TREATMENT OUTCOME; BAYES THEOREM; DIABETES COMPLICATIONS; MORTALITY; STENT;

BAYES THEOREM; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; FOLLOW-UP STUDIES; HUMANS; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; STENTS;

EID: 84927565211     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-0808     Document Type: Review

References (62)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94: 311-21. [PMID: 22079683] doi: 10.1016/j.diabres.2011.10.029
2. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001;44 Suppl 2: S14-21. [PMID: 11587045]
3. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375: 2215-22. [PMID: 20609967] doi: 10.1016/S0140-6736(10)60484-9
4. Smith SC Jr, Faxon D, Cascio W, Schaff H, Gardner T, Jacobs A, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: Revascularization in diabetic patients. Circulation. 2002;105: E165-9. [PMID: 11994268]
5. Henderson RA, Raskino C, Karani S, Sowton E. Comparative long-term results of coronary angioplasty in single and multivessel disease. Eur Heart J. 1992;13: 781-6. [PMID: 1623867]
6. Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, et al. Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: A 3-year clinical outcome study. The diabetes and drug eluting stent for LeFT main registry (D-DELFT). EuroIntervention. 2008;4: 77-83. [PMID: 19112783]
7. Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW. Coronary revascularization trends in the United States, 2001-2008. JAMA. 2011;305: 1769-76. [PMID: 21540420] doi: 10.1001/jama.2011.551
8. Cao C, Manganas C, Bannon P, Vallely M, Yan TD. Drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease: A meta-analysis of early outcomes from randomized and nonrandomized studies. J Thorac Cardiovasc Surg. 2013;145: 738-47. [PMID: 22405674] doi: 10.1016/j.jtcvs.2012.02.004
9. From AM, Al Badarin FJ, Cha SS, Rihal CS. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass surgery for multivessel coronary artery disease: A meta-analysis of data from the ARTS II, CARDia, ERACI III, and SYNTAX studies and systematic review of observational data. EuroIntervention. 2010;6: 269-76. [PMID: 20562080] doi: 10.4244/
10. Verma S, Farkouh ME, Yanagawa B, Fitchett DH, Ahsan MR, Ruel M, et al. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: A meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol. 2013;1: 317-28. [PMID: 24622417] doi: 10.1016/S2213-8587(13)70089-5
11. Sipahi I, Akay M, Dagdelen S, Blitz A, Alhan C. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: Meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Intern Med. 2014;174: 223-30. doi: 10.1001/jamainternmed.2013.12844
12. Mauri L. Endeavor safety: Pooled analysis of early and late safety of a zotarolimus-eluting stent [Abstract]. Presented at Transcatheter Cardiovascular Therapeutics 2007, Washington, DC, 24 October 2007. Abstract no. TCT-375.
13. Mauri L, Massaro JM, Jiang S, Meredith I, Wijns W, Fajadet J, et al. Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents. JACC Cardiovasc Interv. 2010;3: 1240-9. [PMID: 21232717] doi: 10.1016/j.jcin.2010.08.021
14. Meredith IT. Endeavor clinical program: Pooled analysis of early and late safety of a zotarolimus-eluting stent [Abstract]. Presented at EuroPCR 2008, Barcelona, Spain, 15 May 2008.
15. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al; Cochrane Bias Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343: D5928. [PMID: 22008217] doi: 10.1136/bmj.d5928
16. Smith TC, Spiegelhalter DJ, Thomas A. Bayesian approaches to randomeffects meta-analysis: A comparative study. Stat Med. 1995;14: 2685-99. [PMID: 8619108]
17. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23: 3105-24. [PMID: 15449338]
18. Higgins JP, Whitehead A. Borrowing strength from external trials in a metaanalysis. Stat Med. 1996;15: 2733-49. [PMID: 8981683]
19. Gelman A. Prior distributions for variance parameters in hierarchical models. Bayesian Anal. 2006;1: 515-33.
20. Brooks SP, Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat.1998;7: 434-55.
21. The R Project for Statistical Computing. R. Version 3.0.1. 2013. Accessed at www.r-project.org/ on 1 October 2014.
22. Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29: 932-44. [PMID: 20213715] doi: 10.1002/sim.3767
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7: 177-88. [PMID: 3802833]
24. Plummer M. JAGS: Just Another Gibbs Sampler. Version 3.2.0. 2013. Accessed at http://mcmc-jags.sourceforge.net/ on 1 June 2014.
25. Bansilal S, Farkouh ME, Hueb W, Ogdie M, Dangas G, Lansky AJ, et al. The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and angiographic profile at study entry. Am Heart J. 2012;164: 591-9. [PMID: 23067919] doi: 10.1016/j.ahj.2012.06.012
26. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, et al; FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367: 2375-84. [PMID: 23121323] doi: 10.1056/NEJMoa1211585
27. Kapur A. Coronary Artery Revascularisation in Diabetes Trial. Presented at European Society of Cardiology 2008, Munich, Germany, 1 September 2008.
28. Kapur A, Hall R, Qureshi A, Malik I, Flather M, Roughton M, et al. Comparison of bare metal stents versus drug-eluting stents in patients with multivessel disease and diabetes: Results from a CARDia trial substudy [Abstract]. Presented at the Annual Scientific Conference of the British Cardiovascular Society 2009, London, United Kingdom, 1 June 2009. Abstract no. 007.
29. Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol. 2010;55: 432-40. [PMID: 20117456] doi: 10.1016/j.jacc.2009.10.014
30. Kapur A, Malik IS, Bagger JP, Anderson JR, Kooner JS, Thomas M, et al. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: Background, aims, and design. Am Heart J. 2005;149: 13-9. [PMID: 15660030]
31. Kamalesh M, Sharp TG, Tang XC, Shunk K, Ward HB, Walsh J, et al; VA CARDS Investigators. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes. J Am Coll Cardiol. 2013; 61: 808-16. [PMID: 23428214] doi: 10.1016/j.jacc.2012.11.044
32. The ARTS (Arterial Revascularization Therapies Study): Background, goals and methods. Int J Cardiovasc Intervent. 1999;2: 41-50. [PMID: 12623386]
33. Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D, et al; ARTS-II Investigators. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. J Am Coll Cardiol. 2008;52: 1957-67. [PMID: 19055986] doi: 10.1016/j.jacc.2008.09.010
34. Macaya C, García-García HM, Colombo A, Morice MC, Legrand V, Kuck KH, et al. One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass sur- gery and bare metal stent: Insights from ARTS-II and ARTS-I. EuroIntervention. 2006;2: 69-76. [PMID: 19755239]
35. Onuma Y, Wykrzykowska JJ, Garg S, Vranckx P, Serruys PW; ARTS I and II Investigators. 5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: Insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials. JACC Cardiovasc Interv. 2011;4: 317-23. [PMID: 21435610] doi: 10.1016/j.jcin.2010.12.004
36. Rodriguez A. Revascularization strategies of coronary multiple vessel disease in diabetic and non diabetic: Insights from the evidence based medicine PCI vs CABG trials [Abstract]. Presented at Congreso Solaci 2007, Buenos Aires, Argentina, July 2007.
37. Rodriguez AE, Grinfeld L, Fernandez-Pereira C, Mieres J, Rodriguez Alemparte M, Berrocal D, et al. Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: One year follow-up results of the ERACI III Trial. EuroIntervention. 2006;2: 53-60. [PMID: 19755237]
38. Rodriguez AE, Maree AO, Mieres J, Berrocal D, Grinfeld L, Fernandez- Pereira C, et al. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J. 2007;28: 2118-25. [PMID: 17656352]
39. Banning AP, Westaby S, Morice MC, Kappetein AP, Mohr FW, Berti S, et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: Comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol. 2010;55: 1067-75. [PMID: 20079596] doi: 10.1016/j.jacc.2009.09.057
40. Kappetein AP, Head SJ, Morice MC, Banning AP, Serruys PW, Mohr FW, et al; SYNTAX Investigators. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg. 2013;43: 1006-13. [PMID: 23413014] doi: 10.1093/ejcts/ezt017
41. Mack MJ, Banning AP, Serruys PW, Morice MC, Taeymans Y, Van Nooten G, et al. Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome. Ann Thorac Surg. 2011; 92: 2140-6. [PMID: 21967819] doi: 10.1016/j.athoracsur.2011.06.028
42. Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR Jr, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase. Am Heart J. 2006;151: 1194-204. [PMID: 16781219]
43. Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med. 2011;364: 1718-27. [PMID: 21463149] doi: 10.1056/NEJMoa1100452
44. Booth J, Clayton T, Pepper J, Nugara F, Flather M, Sigwart U, et al; SoS Investigators. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: Six-year follow-up from the Stent or Surgery Trial (SoS). Circulation. 2008;118: 381-8. [PMID: 18606919] doi: 10.1161/CIRCULATIONAHA.107. 739144
45. Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, et al. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol. 2009;54: 894-902. [PMID: 19712798] doi: 10.1016/j.jacc.2009.04.077
46. Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Alfonso F, Hernández- Antolín R, SanMartín M, et al; DIABETES Investigators. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: Long-term results of the DIABETES trial. Eur Heart J. 2007; 28: 1946-52. [PMID: 17562666]
47. Sinning JM, Baumgart D, Werner N, Klauss V, Baer FM, Hartmann F, et al; SCORPIUS Study. Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: A German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients. Am Heart J. 2012;163: 446-53. [PMID: 22424016] doi: 10.1016/j.ahj.2011.12.010
48. Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, et al. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: Pooled analysis from 5 randomized trials. J Am Coll Cardiol. 2008;51: 708-15. [PMID: 18279734] doi: 10.1016/j.jacc.2007.10.03549.
49. Maresta A, Varani E, Balducelli M, Varbella F, Lettieri C, Uguccioni L, et al; DESSERT Investigators. Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study). Am J Cardiol. 2008;101: 1560-6. [PMID: 18489933] doi: 10.1016/j.amjcard.2008.01.040
50. Chan C, Zambahari R, Kaul U, Lau CP, Whitworth H, Cohen S, et al; DECODE Investigators. A randomized comparison of sirolimus-eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: The DECODE study. Catheter Cardiovasc Interv. 2008;72: 591-600. [PMID: 18949772] doi: 10.1002/ccd.21719
51. Mauri L, Massaro JM, Jiang S, Meredith I, Wijns W, Fajadet J, et al. Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents. JACC Cardiovasc Interv. 2010;3: 1240-9. [PMID: 21232717] doi: 10.1016/j.jcin.2010.08.021
52. Sedlis SP, Morrison DA, Lorin JD, Esposito R, Sethi G, Sacks J, et al; Investigators of the Dept. of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: Outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol. 2002;40: 1555-66. [PMID: 12427406]
53. Lima EG, Hueb W, Garcia RM, Pereira AC, Soares PR, Favarato D, et al. Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial. Am Heart J. 2013;166: 250-7. [PMID: 23895807] doi: 10.1016/j.ahj. 2013.04.017
54. Kelbaek H, Kløvgaard L, Helqvist S, Lassen JF, Krusell LR, Engstrøm T, et al. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial. J Am Coll Cardiol. 2008;51: 2011-6. [PMID: 18498953] doi: 10.1016/j.jacc.2008.01.056
55. Kissel CK, Kaiser C. The BASKET study program: Continued evaluation of the efficacy and safety of drug-eluting stents. Interventional Cardiology. 2011;3: 461-6. doi: 10.2217/ica.11.44
56. Pache J, Dibra A, Mehilli J, Dirschinger J, Schömig A, Kastrati A. Drugeluting stents compared with thin-strut bare stents for the reduction of restenosis: A prospective, randomized trial. Eur Heart J. 2005;26: 1262-8. [PMID: 15737962]
57. Suttorp MJ, Laarman GJ, Rahel BM, Kelder JC, Bosschaert MA, Kiemeneij F, et al. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation. 2006;114: 921-8. [PMID: 16908768]
58. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997;96: 1761-9. [PMID: 9323059]
59. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: Executive summary and recommendations: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). Circulation. 1999;100: 1464-80. [PMID: 10500052]
60. Klein LW. Are drug-eluting stents the preferred treatment for multivessel coronary artery disease? J Am Coll Cardiol. 2006;47: 22-6. [PMID: 16386659]
61. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med. 2002;21: 2313-24. [PMID: 12210616]
62. Salanti G, Higgins JP, Ades AE, Ioannidis JP. Evaluation of networks of randomized trials. Stat Methods Med Res. 2008;17: 279-301. [PMID: 17925316]